SEC 13F Intelligence

Avidity Partners Management LP / SRPT

Avidity Partners Management LP’s Sarepta Therapeutics Inc Position

Does Avidity Partners Management LP own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 450.0K shares worth $55M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$55M
Q3 2023
Shares
450.0K
% of Portfolio
+2.20%
Quarters Held
6
position exited

Position History SRPT

Reported value by quarter
Q4 ’20: $37MQ4 ’20Q3 ’22: $105MQ3 ’22Q4 ’22: $137MQ4 ’22Q1 ’23: $57MQ1 ’23Q2 ’23: $34MQ2 ’23Q3 ’23: $55MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023450.0K$55M+2.20%
Q2 2023297.5K$34M+1.19%
Q1 2023416.0K$57M+1.90%
Q4 20221.05M$137M+2.96%
Q3 2022948.2K$105M+2.13%
Q4 2020217.4K$37M+1.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of SRPT.